Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry.

[1]  S. Ralston,et al.  FOCAL OSTEOMALACIA DUE TO LOW-DOSE DIPHOSPHONATE THERAPY IN PAGET'S DISEASE , 1984, The Lancet.

[2]  E. Vignon,et al.  Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day). , 1983, Clinical orthopaedics and related research.

[3]  M. Chapuy,et al.  INTRAVENOUS ETIDRONATE FOR SPINAL CORD DYSFUNCTION DUE TO PAGET'S DISEASE , 1982, The Lancet.

[4]  A. Jung.  Comparison of two parenteral diphosphonates in hypercalcemia of malignancy. , 1982, The American journal of medicine.

[5]  E. Siris,et al.  Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate. , 1981, Annals of internal medicine.

[6]  J. Coindre,et al.  Bone histomorphometry in Paget's disease. Quantitative and dynamic analysis of pagetic and nonpagetic bone tissue. , 1980, Arthritis and rheumatism.

[7]  E. Vignon,et al.  Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases. , 1980, The Journal of clinical investigation.

[8]  E. Siris,et al.  Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma. , 1980, The New England journal of medicine.

[9]  O. Bijvoet,et al.  INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.) , 1979, The Lancet.

[10]  R. Altman,et al.  Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results. , 1977, Annals of internal medicine.

[11]  R. Altman,et al.  Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans). , 1973, The New England journal of medicine.

[12]  J. Potts.  Hormonal Control of Calcium Metabolism , 1971 .

[13]  H. Fleisch,et al.  Diphosphonates Inhibit Hydroxyapatite Dissolution in vitro and Bone Resorption in Tissue Culture and in vivo , 1969, Science.

[14]  P. Meunier,et al.  Intermethod variation in bone histomorphometry: comparison between manual and computerized methods applied to iliac bone biopsies. , 1985, Bone.

[15]  J. Compston,et al.  Direct and indirect measurements of osteoid seam width in human iliac crest trabecular bone. , 1984, Metabolic bone disease & related research.

[16]  H. Fleisch.  Diphosphonates: history and mechanisms of action. , 1981, Metabolic bone disease & related research.

[17]  J. Koeller,et al.  Iv dichloromethylene diphosphonate in cancer-associated hypercalcemia: a phase I-II evaluation. , 1981, Cancer treatment reports.

[18]  P. Meunier,et al.  Effects of ethane-1 hydroxy-1, 1-diphosphonate (5 mg/kg/day dose) on quantitative bone histology in Paget's disease of bone. , 1981, Metabolic bone disease & related research.

[19]  R. Canfield,et al.  Diphosphonate therapy of paget's disease of bone. , 1977, The Journal of clinical endocrinology and metabolism.